United States · Exchanges & live quotes · Investopedia
Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data
Moderna shares are taking a hit after the leak of highly anticipated details about the company’s vaccine for the skin cancer melanoma.
Read the full article on Investopedia Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investopedia.com)


